24/04/2014 - 17:35
ORLANDO – Duloxetine for the treatment of late-life depression missed its primary end point in a recent large randomized trial, but it did result in consistently significant clinical improvement,...
Field of Interest: Geriatrics
Categories:
News Feed: Internal Medicine News - Geriatrics